According to the recent report published by Decision foresight, Global Hospital-Acquired Disease Testing Market held USD 1108.6 million in 2020 and is to grow with a CAGR of over 19.8% from 2020-2030. Hospital-acquired disease and nosocomial infection is a localized or general condition in patients that occurs during medical care due to adverse reactions caused by infectious toxin agents, which were absent at admission in hospitals. Hospital-acquired infections result in prolonged hospital stay, resistance to antimicrobials, long-term disabilities and increased mortality rates.

The report titled "Hospital-Acquired Disease Testing Market - Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast - 2020 – 2030" offers a holistic view of the `Hospital-Acquired Disease Testing industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others. Furthermore, the report includes detailed quantitative and qualitative analysis of the global Hospital-Acquired Disease Testing Market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry.

Browse Full report on Global Hospital-Acquired Disease Testing Market at https://www.decisionforesight.com/reports/hospital-acquired-disease...

Hospital-Acquired Disease Testing Market report summarizes the positive growth rate inupcoming years, and market size with competitive analysis. Our experts have analyzed the historical data to compare with the current market scenario to calculate the market growth in the coming years. The study provides an exhaustive report that includes an executive summary, scope, and forecast of the market.

Key Questions Answered by Hospital-Acquired Disease Testing Market Report

Product popularity and adoption based on various country-level dynamics

Regional presence and product development for leading market participants

Market forecasts and trend analysis based on ongoing investments and economic growth in key countries

Competitive landscape based on revenue, product offerings, years of presence, number of employees and market concentration, among others

Number of employees and market concentration, among others

To know more about this study, request a free Sample: https://www.decisionforesight.com/request-sample/DFS020394

Key Players:

Abbott Laboratories
Alere, Inc.
Becton, Dickinson and Company
bioMérieux SA
Hoffmann-La Roche Ltd
Hologic, Inc
Siemens Healthcare
Diatherix Laboratories, Inc.
Meridian Bioscience, Inc.
Thermo Fisher Scientific,
Market Segmentation:

By Testing Type

Urinary Tract Infection
Surgical Site Infection
Pneumonia Stents
Blood Stream Infection
Methicillin-resistant Staphylococcus Aureus (MRSA))
By Geography

North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia Pacific
ROW
Latin America
Middle Eas
Africa
Request Customization @ https://www.decisionforesight.com/customization/DFS020394

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact Us:

Name: Aloke Kumar

(Business Sale Manager)

Email Id: [email protected]

Website: https://www.decisionforesight.com/